Today we welcome Johan Glindre to SpectraCure. Johan Glindre will work as a Clinical Project Leader and has a solid background in clinical studies, project management and quality work. Johan, with a master’s in molecular biology at Lund University, has worked at Pharmacia and OctaPharma, among other things, with quality work in laboratory and method development. At CanImGuide, he has, in recent years, project facilitated and coordinated human clinical studies as well as preclinical studies in animals.
– I am very much looking forward to participating in SpectraCure’s clinical studies and projects going forward, as well as building contacts with clinics and setting up networks, says Johan Glindre.
– It feels good to strengthen the competence within the company with a Clinical Project Leader who will, among other things, work on developing our already established contacts in the clinical studies, but also on developing new contacts, says Johannes Swartling, CTO SpectraCure.
Annika Andersson, the company’s communications manager since September 1, 2019, has taken a place in the company’s management team.
– It is natural for Annika to take a seat in the company’s management team. Communication is an important component of the connection between vision, decision, leadership and executive. She has the necessary communication skills and experience and contributes with a communicative perspective in our joint work, internally as well as externally, says Masoud Khayyami, CEO SpectraCure.
– During the autumn I have been involved in the business issues to be able to participate in discussions and to create strategies and structures for communication and marketing work. This work is ongoing and I am glad that together with the others in the management group, I can contribute to driving SpectraCure forward, says Annika Andersson.